1st SOHO Asia hopes to empower hematology community across Asia
Dr. Hsin-An Hou, a professor at National Taiwan University Hospital, shares his excitement about the regional impact of the inaugural.
FDA grants breakthrough designation to CAR-T therapy sofi-cel
SOHO Insider Editors
January 21, 2026
Sofi-cel, an allogeneic, off-the-shelf, CD7-targeted CAR-T cell therapy, has previously received regenerative medicine advanced therapy, fast track, orphan drug, and rare pediatric disease designations from the FDA and Priority Medicines Scheme designation in the European Union for the treatment of both disease.
